InsidersTradesSigma
Track the Xenetic Biosciences, Inc. share price and the full management transaction log of the company, a listed issuer based in United States. Shares are listed on US US, under the supervision of SEC (Form 4). Market capitalisation: €6.3m. The latest transaction was reported on 23 April 2026 (Attribution). Among the most active insiders: PARSLOW JAMES F. The full history is accessible without an account.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
Xenetic Biosciences, Inc. is a biopharmaceutical company focused on developing innovative therapies for serious diseases. It leverages advanced technologies to enhance the effectiveness of treatments.